This means that its subject to patents held by the original manufacturer, which prevents other companies from manufacturing their own versions of this medication for sale in the United States until those patents expire (the last patents for Invokana expire in July 2024)
Second Natures medication programme Second Nature provides Mounjaro as part of our Mounjaro weight-loss programme
McDonalds, the worlds largest fast-food chain, claims that it has not yet seen an impact on their business due to GLP-1 drugs, but acknowledges that future impact is uncertain
Similar content being viewed by others Introduction The number of people living with type 2 diabetes (T2D) is ever-growing
Human drug compounding, Food and Drug Administration (2024) Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) FDA drug shortages: Semaglutide injection, Food and Drug Administration FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) Ozempic, DailyMed (2024) Find out if your insurance covers Ozempic, Novo Nordisk FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) Company statement: Novo Nordisk escalates legal actions to safeguard patients from potentially harmful compounded semaglutide drugs, Novo Nordisk (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
